Dallan Murray

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Dallan Murray
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dallan Murray:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Chief Customer Officer Common Stock 38,202 $3,825,166 $100.13 10 Mar 2025 Direct
Sarepta Therapeutics, Inc. Chief Customer Officer Performance Restricted Stock Units 17,500 $2,056,425 $117.51 11 Feb 2025 Direct
Sarepta Therapeutics, Inc. Chief Customer Officer Performance Stock Units 0 $0 $103.70 07 Mar 2025 Direct
Sarepta Therapeutics, Inc. Chief Customer Officer Stock Options (right to buy) 16,644 10 Mar 2025 Direct

Insider Reports Filed by Dallan Murray

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRPT Sarepta Therapeutics, Inc. 07 Mar 2025 6 -$373,785 4 Chief Customer Officer 11 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 06 Mar 2025 4 -$950,099 4 Chief Customer Officer 10 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 04 Mar 2025 1 -$170,758 4 Chief Customer Officer 06 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 03 Mar 2025 1 -$73,780 4 Chief Customer Officer 04 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 11 Feb 2025 1 $0 4 Chief Customer Officer 13 Feb 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 21 Jun 2024 5 -$387,233 4 Chief Customer Officer 25 Jun 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 02 May 2024 1 -$508,900 4 Chief Customer Officer 06 May 2024, 20:09
SRPT Sarepta Therapeutics, Inc. 24 Apr 2024 0 $0 3 Chief Customer Officer 06 May 2024, 20:00